AEON Biopharma, Inc. SEC filings AEON
AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 21, 2026 | — |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| 3 | Initial insider ownership | Aug 21, 2026 | Aug 19, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 21, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 3 | Initial insider ownership | Jan 29, 2026 | Jan 21, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 29, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 9, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 30, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 4 | Insider transaction | May 1, 2025 | Apr 29, 2025 |
| 3 | Initial insider ownership | May 1, 2025 | Apr 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 10, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 4/A | Ownership document | Sep 10, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 31, 2024 |
| 144 | Notice of proposed sale | Jul 29, 2024 | — |
| 3 | Initial insider ownership | May 24, 2024 | May 17, 2024 |
| 3 | Initial insider ownership | Apr 18, 2024 | Apr 12, 2024 |
| 4/A | Filing | Apr 16, 2024 | Apr 12, 2024 |
| 4 | Insider transaction | Apr 12, 2024 | Apr 11, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 24, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 22, 2023 | — |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 3 | Initial insider ownership | Jul 31, 2023 | Jul 21, 2023 |
| SC 13D | Ownership over 5% (active) | Jul 31, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jul 31, 2023 | — |
| SC 13D | Ownership over 5% (active) | Jul 28, 2023 | — |
| 3 | Initial insider ownership | Jul 28, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 26, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 20, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 12, 2023 | — |
| 4 | Insider transaction | Mar 31, 2023 | Feb 20, 2023 |
| 3 | Initial insider ownership | Mar 31, 2023 | Feb 20, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 22, 2021 | — |
| 3 | Initial insider ownership | Feb 8, 2021 | Feb 8, 2021 |
| 3 | Initial insider ownership | Feb 8, 2021 | Feb 8, 2021 |
| 3 | Initial insider ownership | Feb 8, 2021 | Feb 8, 2021 |
| 3 | Initial insider ownership | Feb 8, 2021 | Feb 8, 2021 |
| 3 | Initial insider ownership | Feb 8, 2021 | Feb 8, 2021 |
Showing 106 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AEON (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837607
- Former names
- Priveterra Acquisition Corp. (until Jul 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.